Inventor

SAMBAIAH THOTA

Inventor

Overview

3→

Patents

2021–2023

Patent span

Human necessities

Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes27%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%

C07DHeterocyclic compounds27%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium18%

PatentTitleYear

11,827,628Compositions and methods for inhibition of the JAK pathway2023 11,667,611Compositions and methods for inhibition of the JAK pathway2023 11,198,689Compositions and methods for inhibition of the JAK pathway2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2023Patents assigned to RIGEL PHARMACEUTICALS INC (3)· patent assignee history

2021–2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
RIGEL PHARMACEUTICALS INC	3	2021–2023

Locations

Location	Patents	Span
US	3	2021–2023